There also a report from Credit Suisse.
Credit Suisse has initiated “underperform” call on Dr Lal Pathlabs with a target of Rs 1,400 a share.
Subscribe To Our Free Newsletter |
There also a report from Credit Suisse.
Credit Suisse has initiated “underperform” call on Dr Lal Pathlabs with a target of Rs 1,400 a share.
Subscribe To Our Free Newsletter |
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!